IDT Australia Limited

Equities

IDT

AU000000IDT0

Biotechnology & Medical Research

Market Closed - Australian S.E. 02:10:19 2024-05-24 am EDT 5-day change 1st Jan Change
0.096 AUD -3.03% Intraday chart for IDT Australia Limited -3.03% -12.73%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
IDT Australia Secures Victorian Government Funding for Cancer Medication Production Facility MT
IDT Australia Signs Master Service Agreement with Sanofi MT
IDT Australia Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Invion Nears Clinical Trial of Cancer Photodynamic Therapy with Drug Substance Production MT
IDT Australia Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
IDT Australia Raises AU$2 Million Via Share Purchase Plan MT
IDT Australia Limited Provides Preliminary Unaudited Revenue Update for the Three Months to End June 2023 CI
IDT Australia to Open AU$2 Million Share Purchase Plan; Shares Rise 3% MT
IDT Australia Completes First Tranche of AU$5 Million Placement MT
IDT Australia Raises AU$5 Million for Capex Program; Shares Fall 28% MT
IDT Australia Limited Reports Sales Results for the Third Quarter Ended March 2023 CI
IDT Australia Achieves Expansion of License to Manufacture Advanced Therapies MT
IDT Achieves Key Milestone with TGA License Upgrade CI
IDT Australia Transitions Interim CEO to Permanent Role MT
IDT Australia Limited Announces the Appointment of Paul McDonald as Chief Executive Officer CI
IDT Australia Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
IDT Australia Chairman to Retire MT
IDT Australia Limited Announces Board Changes CI
IDT Australia Names Acting CFO MT
IDT Australia Limited Announces Appointment of Mark Licciardo as Company Secretary CI
IDT Australia Limited Announces Appointment of Mahendran Vasanthakumar as Acting CFO CI
IDT Australia Limited Announces Executive Changes CI
IDT Australia Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
MedAdvisor Names Finance Chief MT
IDT Australia's CFO Resigns MT
Chart IDT Australia Limited
More charts
IDT Australia Limited is a pharmaceutical manufacturing company. The Company is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. Its business includes research and development, active pharmaceutical ingredient (API) and finished dosage form manufacture (FDF), clinical and commercial, project management, chemical services, analytical chemistry, pharmacy services, pharmaceutical development in all dosage forms, clinical packaging and regulatory affairs services. Its Current Good Manufacturing Practice (cGMP) manufacturing facilities produces both API and FDF across the medicinal cannabis manufacturing space. It also provides a full-scale service for new drug development and scale-up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms. Its analytical laboratories offer medicinal cannabis cGMP testing.
More about the company
  1. Stock Market
  2. Equities
  3. IDT Stock
  4. News IDT Australia Limited
  5. IDT Australia Signs Master Service Agreement with Sanofi